Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Naturlose (D-Tagatose) Efficacy Evaluation Trial

ClinicalTrials.gov ID: NCT00955747

Public ClinicalTrials.gov record NCT00955747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of Naturlose (Tagatose) on Glycemic Control and Safety of Naturlose Over One Year in Subjects With Type 2 Diabetes Under Diet Control and Exercise

Study identification

NCT ID
NCT00955747
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Robert Lodder
Industry
Enrollment
494 participants

Conditions and interventions

Interventions

  • Tagatose Drug
  • Sugar Substitute Splenda Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2007
Primary completion
Sep 30, 2010
Completion
Sep 30, 2010
Last update posted
Nov 18, 2014

2007 – 2010

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Simon Williamson Clinc Hueytown Alabama 35023
Medical Affiliated Research Center Huntsville Alabama 35801
NEA Clinical-Research Solutions Jonesboro Arkansas 72404
Alia Clinical Research Huntington Park California 90255
Atlanta Primary Care Center Atlanta Georgia 30312
River Birch Research Alliance Blue Ridge Georgia 30513
Affinity Healthcare Arlington Heights Illinois 60004
John Stroger Cook County Hospital Chicago Illinois 60612
University of Kentucky Lexington Kentucky 40502
Activmed Practices and Research Haverhill Massachusetts 01830
Nevada Alliance Against Diabetes Las Vegas Nevada 89101
Ocean County Clinical Research Brick New Jersey 08724
Cedar Clinical Research Oradell New Jersey 07649
Hamilton Clinical Research Trenton New Jersey 08690
ReSevo, LLC Cuyahoga Falls Ohio 44223
Capital Medical Clinic Austin Texas 78705
TTS Research/Hill Country Medical Boerne Texas 78006
Galenos Research Dallas Texas 75251
Century Clinical Research Houston Texas 77036
Cetero Research San Antonio Texas 78229
Optimum Clinical Research Salt Lake City Utah 84102

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00955747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00955747 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →